Takeda to buy out Abbott in U.S. joint venture, source says

03/19/2008 | Bloomberg1 · Reuters

Japanese drugmaker Takeda Pharmaceutical Co. Ltd. is reportedly trying to buy Abbott Laboratories' 50% stake in their U.S. venture for $5 billion. The companies declined to comment on the rumored buyout, which would have Takeda taking over TAP Pharmaceutical Products, but with Abbott getting the venture's prostate cancer division and the rights to some of Takeda's drug candidates.

View Full Article in:

Bloomberg1 · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID